Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events

Development of an artificial pancreas based on an automatic closed-loop algorithm that uses a subcutaneous insulin pump and continuous glucose sensor is a goal for biomedical engineering research. However, closing the loop for the artificial pancreas still presents many challenges, including model i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of diabetes science and technology 2010-07, Vol.4 (4), p.961-975
Hauptverfasser: Grosman, Benyamin, Dassau, Eyal, Zisser, Howard C, Jovanovic, Lois, Doyle, 3rd, Francis J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 975
container_issue 4
container_start_page 961
container_title Journal of diabetes science and technology
container_volume 4
creator Grosman, Benyamin
Dassau, Eyal
Zisser, Howard C
Jovanovic, Lois
Doyle, 3rd, Francis J
description Development of an artificial pancreas based on an automatic closed-loop algorithm that uses a subcutaneous insulin pump and continuous glucose sensor is a goal for biomedical engineering research. However, closing the loop for the artificial pancreas still presents many challenges, including model identification and design of a control algorithm that will keep the type 1 diabetes mellitus subject in normoglycemia for the longest duration and under maximal safety considerations. An artificial pancreatic beta-cell based on zone model predictive control (zone-MPC) that is tuned automatically has been evaluated on the University of Virginia/University of Padova Food and Drug Administration-accepted metabolic simulator. Zone-MPC is applied when a fixed set point is not defined and the control variable objective can be expressed as a zone. Because euglycemia is usually defined as a range, zone-MPC is a natural control strategy for the artificial pancreatic beta-cell. Clinical data usually include discrete information about insulin delivery and meals, which can be used to generate personalized models. It is argued that mapping clinical insulin administration and meal history through two different second-order transfer functions improves the identification accuracy of these models. Moreover, using mapped insulin as an additional state in zone-MPC enriches information about past control moves, thereby reducing the probability of overdosing. In this study, zone-MPC is tested in three different modes using unannounced and announced meals at their nominal value and with 40% uncertainty. Ten adult in silico subjects were evaluated following a scenario of mixed meals with 75, 75, and 50 grams of carbohydrates (CHOs) consumed at 7 am, 1 pm, and 8 pm, respectively. Zone-MPC results are compared to those of the "optimal" open-loop preadjusted treatment. Zone-MPC succeeds in maintaining glycemic responses closer to euglycemia compared to the "optimal" open-loop treatment in te three different modes with and without meal announcement. In the face of meal uncertainty, announced zone-MPC presented only marginally improved results over unannounced zone-MPC. When considering user error in CHO estimation and the need to interact with the system, unannounced zone-MPC is an appealing alternative. Zone-MPC reduces the variability of control moves over fixed set point control without the need to detune the controller. This strategy gives zone-MPC the ability to act quickly when neede
doi_str_mv 10.1177/193229681000400428
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2909531</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>749025735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4228-dae09022838039104e9255d4fe4785092cd3876eb9e7cba4e738db454e2f2da73</originalsourceid><addsrcrecordid>eNplUU1LAzEQDaLYWv0DHiQ3T6v52s3GgyDFLxC81IuXkCbTNrK7qcm2sP56t7QWRRiYx8yb94YZhM4puaJUymuqOGOqKCkhRPTBygM03BQzTok83OENY4BOUvogJBellMdowEhRcFHwIZq8hwZwHRxUeBnBedv6NWAbmjaG6gYbnNpoWph3uA249o2v_RfgRbeEmGHTuA0M86qzUHuLYQ1Nm07R0cxUCc52eYTeHu4n46fs5fXxeXz3klnBWJk5A0SRHvGScEWJAMXy3IkZCFnmRDHreCkLmCqQdmoESF66qcgFsBlzRvIRut3qLlfTGpztvaOp9DL62sROB-P1307jF3oe1poponJOe4HLnUAMnytIra59slBVpoGwSlqKfr9c8rxnsi3TxpBShNnehRK9-Yb-_41-6OL3fvuRn_Pzby34hhA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>749025735</pqid></control><display><type>article</type><title>Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events</title><source>MEDLINE</source><source>SAGE Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Grosman, Benyamin ; Dassau, Eyal ; Zisser, Howard C ; Jovanovic, Lois ; Doyle, 3rd, Francis J</creator><creatorcontrib>Grosman, Benyamin ; Dassau, Eyal ; Zisser, Howard C ; Jovanovic, Lois ; Doyle, 3rd, Francis J</creatorcontrib><description>Development of an artificial pancreas based on an automatic closed-loop algorithm that uses a subcutaneous insulin pump and continuous glucose sensor is a goal for biomedical engineering research. However, closing the loop for the artificial pancreas still presents many challenges, including model identification and design of a control algorithm that will keep the type 1 diabetes mellitus subject in normoglycemia for the longest duration and under maximal safety considerations. An artificial pancreatic beta-cell based on zone model predictive control (zone-MPC) that is tuned automatically has been evaluated on the University of Virginia/University of Padova Food and Drug Administration-accepted metabolic simulator. Zone-MPC is applied when a fixed set point is not defined and the control variable objective can be expressed as a zone. Because euglycemia is usually defined as a range, zone-MPC is a natural control strategy for the artificial pancreatic beta-cell. Clinical data usually include discrete information about insulin delivery and meals, which can be used to generate personalized models. It is argued that mapping clinical insulin administration and meal history through two different second-order transfer functions improves the identification accuracy of these models. Moreover, using mapped insulin as an additional state in zone-MPC enriches information about past control moves, thereby reducing the probability of overdosing. In this study, zone-MPC is tested in three different modes using unannounced and announced meals at their nominal value and with 40% uncertainty. Ten adult in silico subjects were evaluated following a scenario of mixed meals with 75, 75, and 50 grams of carbohydrates (CHOs) consumed at 7 am, 1 pm, and 8 pm, respectively. Zone-MPC results are compared to those of the "optimal" open-loop preadjusted treatment. Zone-MPC succeeds in maintaining glycemic responses closer to euglycemia compared to the "optimal" open-loop treatment in te three different modes with and without meal announcement. In the face of meal uncertainty, announced zone-MPC presented only marginally improved results over unannounced zone-MPC. When considering user error in CHO estimation and the need to interact with the system, unannounced zone-MPC is an appealing alternative. Zone-MPC reduces the variability of control moves over fixed set point control without the need to detune the controller. This strategy gives zone-MPC the ability to act quickly when needed and reduce unnecessary control moves in the euglycemic range.</description><identifier>ISSN: 1932-2968</identifier><identifier>EISSN: 1932-3107</identifier><identifier>DOI: 10.1177/193229681000400428</identifier><identifier>PMID: 20663463</identifier><language>eng</language><publisher>United States: Diabetes Technology Society</publisher><subject>Adult ; Algorithms ; Blood Glucose - analysis ; Blood Glucose Self-Monitoring ; Computer Simulation ; Diabetes Mellitus, Type 1 - complications ; Diabetes Mellitus, Type 1 - drug therapy ; Dietary Carbohydrates ; Eating ; Humans ; Hyperglycemia - blood ; Hyperglycemia - prevention &amp; control ; Hypoglycemia - blood ; Hypoglycemia - prevention &amp; control ; Hypoglycemic Agents - administration &amp; dosage ; Hypoglycemic Agents - therapeutic use ; Insulin - administration &amp; dosage ; Insulin - therapeutic use ; Insulin Infusion Systems ; Models, Statistical ; Original ; Pancreas, Artificial ; Predictive Value of Tests ; Regression Analysis</subject><ispartof>Journal of diabetes science and technology, 2010-07, Vol.4 (4), p.961-975</ispartof><rights>2010 Diabetes Technology Society.</rights><rights>2010 Diabetes Technology Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4228-dae09022838039104e9255d4fe4785092cd3876eb9e7cba4e738db454e2f2da73</citedby><cites>FETCH-LOGICAL-c4228-dae09022838039104e9255d4fe4785092cd3876eb9e7cba4e738db454e2f2da73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909531/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909531/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20663463$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grosman, Benyamin</creatorcontrib><creatorcontrib>Dassau, Eyal</creatorcontrib><creatorcontrib>Zisser, Howard C</creatorcontrib><creatorcontrib>Jovanovic, Lois</creatorcontrib><creatorcontrib>Doyle, 3rd, Francis J</creatorcontrib><title>Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events</title><title>Journal of diabetes science and technology</title><addtitle>J Diabetes Sci Technol</addtitle><description>Development of an artificial pancreas based on an automatic closed-loop algorithm that uses a subcutaneous insulin pump and continuous glucose sensor is a goal for biomedical engineering research. However, closing the loop for the artificial pancreas still presents many challenges, including model identification and design of a control algorithm that will keep the type 1 diabetes mellitus subject in normoglycemia for the longest duration and under maximal safety considerations. An artificial pancreatic beta-cell based on zone model predictive control (zone-MPC) that is tuned automatically has been evaluated on the University of Virginia/University of Padova Food and Drug Administration-accepted metabolic simulator. Zone-MPC is applied when a fixed set point is not defined and the control variable objective can be expressed as a zone. Because euglycemia is usually defined as a range, zone-MPC is a natural control strategy for the artificial pancreatic beta-cell. Clinical data usually include discrete information about insulin delivery and meals, which can be used to generate personalized models. It is argued that mapping clinical insulin administration and meal history through two different second-order transfer functions improves the identification accuracy of these models. Moreover, using mapped insulin as an additional state in zone-MPC enriches information about past control moves, thereby reducing the probability of overdosing. In this study, zone-MPC is tested in three different modes using unannounced and announced meals at their nominal value and with 40% uncertainty. Ten adult in silico subjects were evaluated following a scenario of mixed meals with 75, 75, and 50 grams of carbohydrates (CHOs) consumed at 7 am, 1 pm, and 8 pm, respectively. Zone-MPC results are compared to those of the "optimal" open-loop preadjusted treatment. Zone-MPC succeeds in maintaining glycemic responses closer to euglycemia compared to the "optimal" open-loop treatment in te three different modes with and without meal announcement. In the face of meal uncertainty, announced zone-MPC presented only marginally improved results over unannounced zone-MPC. When considering user error in CHO estimation and the need to interact with the system, unannounced zone-MPC is an appealing alternative. Zone-MPC reduces the variability of control moves over fixed set point control without the need to detune the controller. This strategy gives zone-MPC the ability to act quickly when needed and reduce unnecessary control moves in the euglycemic range.</description><subject>Adult</subject><subject>Algorithms</subject><subject>Blood Glucose - analysis</subject><subject>Blood Glucose Self-Monitoring</subject><subject>Computer Simulation</subject><subject>Diabetes Mellitus, Type 1 - complications</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Dietary Carbohydrates</subject><subject>Eating</subject><subject>Humans</subject><subject>Hyperglycemia - blood</subject><subject>Hyperglycemia - prevention &amp; control</subject><subject>Hypoglycemia - blood</subject><subject>Hypoglycemia - prevention &amp; control</subject><subject>Hypoglycemic Agents - administration &amp; dosage</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Insulin - administration &amp; dosage</subject><subject>Insulin - therapeutic use</subject><subject>Insulin Infusion Systems</subject><subject>Models, Statistical</subject><subject>Original</subject><subject>Pancreas, Artificial</subject><subject>Predictive Value of Tests</subject><subject>Regression Analysis</subject><issn>1932-2968</issn><issn>1932-3107</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplUU1LAzEQDaLYWv0DHiQ3T6v52s3GgyDFLxC81IuXkCbTNrK7qcm2sP56t7QWRRiYx8yb94YZhM4puaJUymuqOGOqKCkhRPTBygM03BQzTok83OENY4BOUvogJBellMdowEhRcFHwIZq8hwZwHRxUeBnBedv6NWAbmjaG6gYbnNpoWph3uA249o2v_RfgRbeEmGHTuA0M86qzUHuLYQ1Nm07R0cxUCc52eYTeHu4n46fs5fXxeXz3klnBWJk5A0SRHvGScEWJAMXy3IkZCFnmRDHreCkLmCqQdmoESF66qcgFsBlzRvIRut3qLlfTGpztvaOp9DL62sROB-P1307jF3oe1poponJOe4HLnUAMnytIra59slBVpoGwSlqKfr9c8rxnsi3TxpBShNnehRK9-Yb-_41-6OL3fvuRn_Pzby34hhA</recordid><startdate>201007</startdate><enddate>201007</enddate><creator>Grosman, Benyamin</creator><creator>Dassau, Eyal</creator><creator>Zisser, Howard C</creator><creator>Jovanovic, Lois</creator><creator>Doyle, 3rd, Francis J</creator><general>Diabetes Technology Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201007</creationdate><title>Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events</title><author>Grosman, Benyamin ; Dassau, Eyal ; Zisser, Howard C ; Jovanovic, Lois ; Doyle, 3rd, Francis J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4228-dae09022838039104e9255d4fe4785092cd3876eb9e7cba4e738db454e2f2da73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Algorithms</topic><topic>Blood Glucose - analysis</topic><topic>Blood Glucose Self-Monitoring</topic><topic>Computer Simulation</topic><topic>Diabetes Mellitus, Type 1 - complications</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Dietary Carbohydrates</topic><topic>Eating</topic><topic>Humans</topic><topic>Hyperglycemia - blood</topic><topic>Hyperglycemia - prevention &amp; control</topic><topic>Hypoglycemia - blood</topic><topic>Hypoglycemia - prevention &amp; control</topic><topic>Hypoglycemic Agents - administration &amp; dosage</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Insulin - administration &amp; dosage</topic><topic>Insulin - therapeutic use</topic><topic>Insulin Infusion Systems</topic><topic>Models, Statistical</topic><topic>Original</topic><topic>Pancreas, Artificial</topic><topic>Predictive Value of Tests</topic><topic>Regression Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grosman, Benyamin</creatorcontrib><creatorcontrib>Dassau, Eyal</creatorcontrib><creatorcontrib>Zisser, Howard C</creatorcontrib><creatorcontrib>Jovanovic, Lois</creatorcontrib><creatorcontrib>Doyle, 3rd, Francis J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of diabetes science and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grosman, Benyamin</au><au>Dassau, Eyal</au><au>Zisser, Howard C</au><au>Jovanovic, Lois</au><au>Doyle, 3rd, Francis J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events</atitle><jtitle>Journal of diabetes science and technology</jtitle><addtitle>J Diabetes Sci Technol</addtitle><date>2010-07</date><risdate>2010</risdate><volume>4</volume><issue>4</issue><spage>961</spage><epage>975</epage><pages>961-975</pages><issn>1932-2968</issn><eissn>1932-3107</eissn><abstract>Development of an artificial pancreas based on an automatic closed-loop algorithm that uses a subcutaneous insulin pump and continuous glucose sensor is a goal for biomedical engineering research. However, closing the loop for the artificial pancreas still presents many challenges, including model identification and design of a control algorithm that will keep the type 1 diabetes mellitus subject in normoglycemia for the longest duration and under maximal safety considerations. An artificial pancreatic beta-cell based on zone model predictive control (zone-MPC) that is tuned automatically has been evaluated on the University of Virginia/University of Padova Food and Drug Administration-accepted metabolic simulator. Zone-MPC is applied when a fixed set point is not defined and the control variable objective can be expressed as a zone. Because euglycemia is usually defined as a range, zone-MPC is a natural control strategy for the artificial pancreatic beta-cell. Clinical data usually include discrete information about insulin delivery and meals, which can be used to generate personalized models. It is argued that mapping clinical insulin administration and meal history through two different second-order transfer functions improves the identification accuracy of these models. Moreover, using mapped insulin as an additional state in zone-MPC enriches information about past control moves, thereby reducing the probability of overdosing. In this study, zone-MPC is tested in three different modes using unannounced and announced meals at their nominal value and with 40% uncertainty. Ten adult in silico subjects were evaluated following a scenario of mixed meals with 75, 75, and 50 grams of carbohydrates (CHOs) consumed at 7 am, 1 pm, and 8 pm, respectively. Zone-MPC results are compared to those of the "optimal" open-loop preadjusted treatment. Zone-MPC succeeds in maintaining glycemic responses closer to euglycemia compared to the "optimal" open-loop treatment in te three different modes with and without meal announcement. In the face of meal uncertainty, announced zone-MPC presented only marginally improved results over unannounced zone-MPC. When considering user error in CHO estimation and the need to interact with the system, unannounced zone-MPC is an appealing alternative. Zone-MPC reduces the variability of control moves over fixed set point control without the need to detune the controller. This strategy gives zone-MPC the ability to act quickly when needed and reduce unnecessary control moves in the euglycemic range.</abstract><cop>United States</cop><pub>Diabetes Technology Society</pub><pmid>20663463</pmid><doi>10.1177/193229681000400428</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-2968
ispartof Journal of diabetes science and technology, 2010-07, Vol.4 (4), p.961-975
issn 1932-2968
1932-3107
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2909531
source MEDLINE; SAGE Complete; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Adult
Algorithms
Blood Glucose - analysis
Blood Glucose Self-Monitoring
Computer Simulation
Diabetes Mellitus, Type 1 - complications
Diabetes Mellitus, Type 1 - drug therapy
Dietary Carbohydrates
Eating
Humans
Hyperglycemia - blood
Hyperglycemia - prevention & control
Hypoglycemia - blood
Hypoglycemia - prevention & control
Hypoglycemic Agents - administration & dosage
Hypoglycemic Agents - therapeutic use
Insulin - administration & dosage
Insulin - therapeutic use
Insulin Infusion Systems
Models, Statistical
Original
Pancreas, Artificial
Predictive Value of Tests
Regression Analysis
title Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T04%3A04%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Zone%20model%20predictive%20control:%20a%20strategy%20to%20minimize%20hyper-%20and%20hypoglycemic%20events&rft.jtitle=Journal%20of%20diabetes%20science%20and%20technology&rft.au=Grosman,%20Benyamin&rft.date=2010-07&rft.volume=4&rft.issue=4&rft.spage=961&rft.epage=975&rft.pages=961-975&rft.issn=1932-2968&rft.eissn=1932-3107&rft_id=info:doi/10.1177/193229681000400428&rft_dat=%3Cproquest_pubme%3E749025735%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=749025735&rft_id=info:pmid/20663463&rfr_iscdi=true